The enactment of adult-use marijuana legalization is not associated with any immediate uptick in the percentage of trauma patients testing positive for past cannabis exposure, according to data published in the Canadian Journal of Surgery. A team of researchers with Western University in London, Ontario evaluated adults admitted into a leading Canadian trauma center in the three months … Continue reading Canada: No uptick in trauma patients testing positive for cannabis after legalization
Tag: medical marijuana
Cannabis policy liberalization is not associated with individual-level patterns of cigarette use.
Their findings are consistent with those of prior studies similarly concluding that the prevalence of cannabis retailers is not positively associated with increases in either marijuana use or access among younger people.
Despite significant increases in levels of cannabis use in our sample, change in cannabis use did not predict changes in motivation.
State medical marijuana laws and recreational marijuana laws are associated with decreases in teen marijuana consumption
Following the daily administration of vaporized plant cannabis, the patient exhibited sustained improvements in speech fluency and also reported benefits to his overall quality of life. The patient did not report any adverse side effects from cannabis over the one-year observational period.
Legal marijuana sales have increased to historic levels in recent months, with sales totaling nearly $6 billion in the first quarter of this year.
House Bill 605 permits physicians to recommend cannabis therapy to patients with opioid use disorder. Some studies have shown that the use of cannabis is associated with greater rates of treatment retention in patients with OUD and that cannabinoids may mitigate opioid-related cravings.
Twenty-five percent of respondents acknowledged either using or having used CBD for symptom control. Nearly half (46 percent) of users reported that it mitigated their pain.
Following treatment, subjects’ average pain intensity declined from baseline by 20 percent. Nearly half of the subjects who had been using analgesic medications at the start of trial were no longer using them by the study’s end.